CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 31, 2022		95,021,760
Balance at beginning of period at Dec. 31, 2022	$ 2,798,389	$ 933	$ 2,362,663	$ 700,040	$ (265,247)
Increase (Decrease) in Stockholders' Equity
Net income	62,562			62,562
Other comprehensive income	2,518				2,518
Cash dividends declared	(31,357)			(31,357)
Dividend equivalents declared	0		122	(122)
Share-based compensation expense	4,729		4,729
Issuance of restricted stock, net (in shares)		834,724
Issuance of restricted stock, net	0	$ 4	(4)
Restricted stock surrendered and canceled (in shares)		(142,175)
Restricted stock surrendered and canceled	(5,691)		(5,691)
Exercise of stock options (in shares)		468
Exercise of stock options	11		11
Balance at end of period (in shares) at Mar. 31, 2023		95,714,777
Balance at end of period at Mar. 31, 2023	$ 2,831,161	$ 937	2,361,830	731,123	(262,729)
Balance at beginning of period (in shares) at Dec. 31, 2023	95,860,092	95,860,092
Balance at beginning of period at Dec. 31, 2023	$ 2,882,581	$ 938	2,377,131	604,137	(99,625)
Increase (Decrease) in Stockholders' Equity
Net income	47,025			47,025
Other comprehensive income	3,909				3,909
Cash dividends declared	(31,635)			(31,635)
Dividend equivalents declared	0		122	(122)
Share-based compensation expense	5,450		5,450
Issuance of restricted stock, net (in shares)		786,501
Issuance of restricted stock, net	0	$ 3	(3)
Restricted stock surrendered and canceled (in shares)		(196,887)
Restricted stock surrendered and canceled	(4,691)		(4,691)
Exercise of stock options (in shares)		10,260
Exercise of stock options	$ 162		162
Balance at end of period (in shares) at Mar. 31, 2024	96,459,966	96,459,966
Balance at end of period at Mar. 31, 2024	$ 2,902,801	$ 941	$ 2,378,171	$ 619,405	$ (95,716)